Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community. These blogs are an opportunity for ophthalmic bloggers to engage with readers with about a topic that is top of mind, whether it is practice management, experiences with patients, the industry, medicine in general, or healthcare reform. The views expressed in these blogs are those of their respective contributors and do not represent the views of Ophthalmology Times or UBM Medica.
I’m a millennial. For my generation, being on Facebook is second nature.
But we’re not alone: More than 1 billion people of all ages use Facebook, including many members of older generations who join to share photos and communicate with extended family and friends.
That’s why in our practice, we use Facebook to reach out to spread the word about how we can help people with glaucoma.
In fact, Facebook has been a much more effective tool than mailings, many of which are dismissed as junk mail or returned as undeliverable because patients have moved.
We were encouraged to expand our Facebook efforts when we began encouraging Yelp and Facebook reviews at our front desk and found that patients choose to leave reviews on Facebook much more often. Although we do have a professional write our posts (they must be concise and engaging), we view the cost as reasonable—like the cost of postage, but with a better reach and return on investment.
Alena Reznik, MD
Dr. Reznik is the assistant professor of clinical ophthalmology and co-director of the glaucoma fellowship program at the University of California Roski Eye Institute. Dr. Reznik is a consultant for Allergan, Glaukos, and Alcon.